Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLDX | AZN | AMGN | GILD | VRTX |
| Company | Celldex Therapeutics | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 26.95 | 90.87 | 324.82 | 120.53 | 455.71 |
| High | 27.16 | 91.57 | 327.34 | 121.64 | 459.05 |
| Low | 26.56 | 90.19 | 323.02 | 118.17 | 452.83 |
| Latest | 26.68 | 91.35 | 326.74 | 118.78 | 454.96 |
| Change | -0.41 | -0.21 | +1.43 | -1.00 | -0.75 |
| % Change | -1.51% | -0.23% | +0.44% | -0.83% | -0.16% |
| Volume | 592,800 | 4,514,800 | 2,642,300 | 6,417,200 | 1,258,600 |
| 20-Day Average Volume | 746,615 | 5,872,755 | 2,879,825 | 7,148,185 | 1,391,315 |
| Previous Close | 27.09 | 91.56 | 325.31 | 119.78 | 455.71 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 27.14 | 90.82 | 332.72 | 123.69 | 439.61 |
| 20-Day Raw Stochastic | 36.01% | 52.45% | 42.23% | 5.79% | 80.38% |
| 20-Day Relative Strength | 50.45 | 58.70 | 53.11 | 44.68 | 60.20 |
| Weighted Alpha | +12.56 | +42.31 | +24.22 | +24.34 | +13.78 |
| Today's Opinion | 88% Buy | 100% Buy | 72% Buy | 56% Buy | 56% Buy |
| Previous Opinion | 88% Buy | 100% Buy | 72% Buy | 56% Buy | 56% Buy |
| Last Month's Opinion | 56% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.02% since 12/09/25 | +1.70% since 12/09/25 | +4.11% since 12/09/25 | -0.49% since 12/09/25 | +4.11% since 12/09/25 |
| Low | 26.56 on 12/16/25 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 433.81 on 12/10/25 |
| High | 28.79 on 12/11/25 | 91.79 on 12/15/25 | 327.34 on 12/16/25 | 123.74 on 12/11/25 | 459.05 on 12/16/25 |
| 1-Month | |||||
| %Chg | +4.42% since 11/14/25 | +2.53% since 11/14/25 | -2.97% since 11/14/25 | -4.99% since 11/14/25 | +4.07% since 11/14/25 |
| Low | 24.53 on 11/19/25 | 88.41 on 11/20/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 418.53 on 11/19/25 |
| High | 30.50 on 12/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +8.54% since 09/16/25 | +17.78% since 09/16/25 | +19.65% since 09/16/25 | +7.14% since 09/16/25 | +16.25% since 09/16/25 |
| Low | 22.10 on 11/11/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 30.50 on 12/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +31.17% since 06/16/25 | +24.20% since 06/16/25 | +10.55% since 06/16/25 | +7.17% since 06/16/25 | +0.90% since 06/16/25 |
| Low | 19.52 on 06/30/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 30.50 on 12/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,800,103 | 283,966,560 | 175,173,264 | 148,608,656 | 115,622,280 |
| Shares Outstanding, K | 66,449 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 7,020,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -157,860,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 730,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -56,600,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.13 | 0.31 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.01 on 11/10/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 02/26/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.66 | 14.53 | 14.70 | 29.53 |